BioAgra’s Agrastim(R) for the replacement of antibiotics in poultry feed
Vyta Corp and Justin Holdings, equal owners of their joint venture, BioAgra, have announced the completion of a successful university study of its product Agrastim, a purified yeast beta-1,3/1,6-D glucan product with an 80% or greater biological activity.
Since the marketplace now is demanding antibiotic-free chickens, it has become necessary for the poultry industry to find new non-antibiotic means to prevent and/or limit the occurrence of necrotic enteritis, amongst other diseases.
The study was conducted at the University of Georgia in Athens, in collaboration with the Southern Poultry Research Institute under the direction of Dr Charles Hofacre and Greg Mathis, Ph.D., president of Southern Poultry Research Institute.
The study was designed to demonstrate that Agrastim
can safely and effectively replace antibiotics in the feed of broilers when challenged by Clostridium perfringens
, the agent that causes necrotic enteritis.
BioAgra expects that under conditions in which subclinical infections are present, Agrastim may perform even better than antibiotics. Agrastim can be used in the feed stock of all living organisms and directly activates both the innate and adaptive immune systems.